Torigen’s Autologous Prescription Product is an experimental biologic used as an autologous cancer immunotherapy after surgical tumor removal. Our experimental prescription cancer vaccine uses the dog’s, cat’s, or horse’s, tumor cells to create an individualized autologous immunotherapy – a cancer treatment that uses the body’s immune system to fight cancer.
Torigen’s laboratory creates a multi-dose vaccine from a surgically removed portion of the tumor that is administered over a three week period.